Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo-pharma

Tag: aurobindo pharma

Read all Latest developments, information and news on and about Aurobindo-pharma - Page 14

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Aurobindo arm, Orion expand licensing deal to commercialize biosimilars pipeline in select European markets

Ruchika Sharma12 Jan 2022 1:18 PM IST

Hyderabad: Aurobindo Pharma Limited (along with its subsidiaries together referred to as "Aurobindo") has announced that its subsidiary CuraTeQ...

Aurobindo Pharma launches COVID-19 drug Molnupiravir

Medical Dialogues Bureau7 Jan 2022 9:00 AM IST

HYDERABAD: Aurobindo Pharma Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India.Molnupiravir is for...

Aurobindo Pharma appoints K Nithyananda Reddy as Managing Director

Ruchika Sharma1 Jan 2022 12:00 PM IST

Hyderabad: Aurobindo Pharma has recently announced the appointment of Mr. K. Nithyananda Reddy as the Managing Director while continuing as the...

Unichem, Aurobindo Pharma recall Topiramate, Carvedilol respectively in US

Ruchika Sharma6 Dec 2021 12:40 PM IST

New Delhi: Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due...

Drug makers make progress tackling drug-resistant infections: AMF

Ruchika Sharma18 Nov 2021 11:00 AM IST

New Delhi: Drugmakers have made some progress in restraining antibiotics overuse, which leads to drug-resistant infections, but have fallen short in...

Aurobindo Pharma gets USFDA OAI status for API facility in Hyderabad

Ruchika Sharma12 Nov 2021 2:33 PM IST

Hyderabad: Drugmaker, Aurobindo Pharma, has recently announced that the company has received Official Action Indicated (OAI) status...

Aurobindo Pharma net profit declines nearly 14 percent to Rs 697 crore in Q2

Ruchika Sharma10 Nov 2021 10:00 AM IST

New Delhi: Drug firm Aurobindo Pharma on Monday reported a 13.69 per cent decline in its consolidated net profit to Rs 696.71 crore in the...

Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate COVID patients

Medical Dialogues Team9 Oct 2021 5:33 PM IST

New Delhi: Seeking approval to end the study of Merck & Co's experimental antiviral drug Molnupiravir in moderate Covid-19 patients, two Indian...

Aurobindo Pharma, Glenmark recall mutliple products in US

Ruchika Sharma4 Oct 2021 1:02 PM IST

New Delhi: Glenmark Pharmaceuticals and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from...

Aurobindo Pharma MD N Govindarajan steps down

Medical Dialogues Team2 Oct 2021 11:35 AM IST

New Delhi: Drug firm Aurobindo Pharma on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the...

Aurobindo Pharma arm submits first biosimilar filing with EMA

Ruchika Sharma23 Sept 2021 10:00 AM IST

Hyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that the company's subsidiary CuraTeQ Biologics Pvt Ltd. has submitted...

Aurobindo Pharma arm gets USFDA okay for Cyclophosphamide Injection

Ruchika Sharma27 Aug 2021 1:19 PM IST

Hyderabad: Aurobindo Pharma Limited today announced that the company's subsidiary Eugia Pharma Specialities Ltd. has received a 505(b)(2) NDA...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok